One minute cure in spanish9/22/2023 ![]() Even if lower-income countries can afford the medicine, they might not have the diagnostic capacity to treat patients with molnupiravir early in the course of their illness, when treatment could make a difference. Molnupiravir was so effective in a phase 3 trial involving COVID-19-positive people at risk of severe illness that clinicians halted enrolment early.īut whether this clinical-trial success story will translate into a global game-changer in the fight against the pandemic isn’t yet clear. ![]() ![]() ![]() It could also keep hospitals from overflowing, especially in places where vaccination rates are still low, such as many low- and lower-middle-income countries. The race for antiviral drugs to beat COVID - and the next pandemicĪ pill could make treating patients earlier on in their infection much easier - and more effective.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |